Subscribe To
CASI / CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022
CASI News
By Market Watch
January 6, 2023
Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China
Shares of Casi Pharmaceuticals Inc. CASI, +3.63% were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical more_horizontal
By PRNewsWire
August 5, 2022
CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022
ROCKVILLE, Md. and BEIJING , Aug. 5, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on devel more_horizontal
By Market Watch
June 2, 2022
CASI Pharmaceuticals stock falls after reverse split takes effect
Shares of CASI Pharmaceuticals Inc. CASI, +18.01% are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. W more_horizontal
By Seeking Alpha
May 12, 2022
CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (NASDAQ:CASI ) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Wei-Wu He - Chairman and Chief more_horizontal
By Zacks Investment Research
May 12, 2022
CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the nu more_horizontal
By Seeking Alpha
March 28, 2022
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Zacks Investment Research
October 6, 2021
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal
By Zacks Investment Research
October 6, 2021
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal